Target intelligence / Profile preview

N-acetylgalactosamine kinase (GALK2)

Target
GALK2
Molecular classification
Enzyme, Kinase, Transferase, GHMP kinase family
01

Overview

N-acetylgalactosamine kinase (GALK2) is a member of the GHMP kinase family and catalyzes the phosphorylation of N-acetyl-D-galactosamine (GalNAc) to N-acetyl-alpha-D-galactosamine 1-phosphate, using ATP as the phosphate donor[2][3][4][7]. GALK2 also has galactokinase activity when galactose is present at high concentrations, but its primary role is in the salvage pathway for recycling GalNAc liberated from the breakdown of complex carbohydrates[3][4][6][7]. The enzyme displays greater efficiency for GalNAc than galactose and plays a role in galactose and GalNAc metabolism. The gene encoding GALK2 is located on chromosome 15q21.1–q21.2 and undergoes alternative splicing[4][7]. GALK2 is linked to inherited metabolic disorders when deficient, but specific drugs or established mechanisms of pharmacological targeting have not been described in the current literature[7].

Other names
GK2GalNAc kinaseN-acetylgalactosamine (GalNAc)-1-phosphate kinaseGalactokinase 2galNAc kinase
02

Biological functions

Phosphorylation of N-acetyl-D-galactosamineSalvage pathway for reutilization of free N-acetyl-D-galactosamine (GalNAc) from complex carbohydrate degradationGalactokinase activity at high galactose concentrations
03

Disease associations

Metabolic disorders (including Galactosemia II and III)

Beyond the preview

Go deeper on N-acetylgalactosamine kinase (GALK2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on N-acetylgalactosamine kinase (GALK2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call